Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials.
Jonathan James Hyett BrayHarri Foster-DaviesAhmed SalemAmy L HooleDaniel Rhys ObaidJulian P J HalcoxJeffrey W StephensPublished in: Diabetes, obesity & metabolism (2021)
There is strong evidence supporting clinically relevant anti-inflammatory and antioxidant effects of GLP-1RAs. This may be used to guide future targeted clinical use of GLP-1RAs and the development of medications seeking to target the cardioprotective properties of GLP-1RAs.